Orthogon Therapeutics

Ali is an experienced entrepreneur with a track record of leading discovery projects from ideation to proof-of-concept and executing M&A transactions. As the CEO, Ali is also a hands-on scientist specializing in difficult to “drug”, frontier targets often referred to as the “high hanging fruits in drug discovery”. Mark is a seasoned Medicinal Chemist who has contributed to the development of 17 innovative small molecules, including 8 compounds that reached clinical development and 1 FDA approved product. Mark has co-authored 65 publications and is a co-inventor on 37 patents. Stephen brings more than twenty years of experience in the fields of biochemistry and structural biology. Previously, Stephen was involved with several innovative programs at Life Sensors Inc in the USA.